Proficio Capital Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
+1,060
New +$324K 0.01% 417
2019
Q3
Sell
-190
Closed -$24K 1560
2019
Q2
$24K Buy
190
+8
+4% +$944 0.01% 623
2019
Q1
$20K Hold
182
0.01% 655
2018
Q4
$18K Hold
182
0.01% 579
2018
Q3
$22K Buy
182
+8
+5% +$897 0.01% 570
2018
Q2
$17K Buy
174
+9
+5% +$828 0.01% 657
2018
Q1
$15K Hold
165
﹤0.01% 687
2017
Q4
$16K Sell
165
-9
-5% -$882 0.01% 658
2017
Q3
$17K Sell
174
-18
-9% -$1.63K 0.01% 642
2017
Q2
$17K Sell
192
-8
-4% -$736 0.01% 658
2017
Q1
$19K Buy
200
+171
+590% +$14.3K 0.01% 637
2016
Q4
$2K Buy
+29
New +$2.28K ﹤0.01% 949

Other funds holding WST

Proficio Capital Partners's WST Position: Q2 2026 in Review

Proficio Capital Partners opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,060 shares worth $381K. The stake represents 0.01% of the portfolio and ranks #417 among its holdings. This is a return to the name: Proficio Capital Partners previously reported a position in WST as recently as Q2 2019.

Proficio Capital Partners first reported a position in WST in Q4 2016 and has held it in 12 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Proficio Capital Partners held 1,060 shares of West Pharmaceutical worth $381K as of Q2 2026.
  • West Pharmaceutical was a new Proficio Capital Partners position in Q2 2026.
  • West Pharmaceutical made up 0.01% of Proficio Capital Partners's portfolio in Q2 2026, its #417 holding.
  • Proficio Capital Partners first reported a position in West Pharmaceutical in Q4 2016 and has held it in 12 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Proficio Capital Partners's 13F filing for Q2 2026, filed 17 Aug 2026.